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Abstract 
Background: The nuclear pore complex (NPC) mediates nuclear transport of RNA and proteins into and out of the 
nucleus. Certain nucleoporins have additional functions in chromatin organization and transcription regulation. 
Nup93 is a scaffold nucleoporin at the nuclear pore complex which is associated with human chromosomes 5, 7 and 
16 and with the promoters of the HOXA gene as revealed by ChIP-on-chip studies using tiling microarrays for these 
chromosomes. However, the functional consequences of the association of Nup93 with HOXA is unknown.
Results: Here, we examined the association of Nup93 with the HOXA gene cluster and its consequences on HOXA 
gene expression in diploid colorectal cancer cells (DLD1). Nup93 showed a specific enrichment ~1 Kb upstream 
of the transcription start site of each of the HOXA1, HOXA3 and HOXA5 promoters, respectively. Furthermore, the 
association of Nup93 with HOXA was assisted by its interacting partners Nup188 and Nup205. The depletion of the 
Nup93 sub-complex significantly upregulated HOXA gene expression levels. However, expression levels of a control 
gene locus (GLCCI1) on human chromosome 7 were unaffected. Three-dimensional fluorescence in situ hybridization 
(3D-FISH) analyses revealed that the depletion of the Nup93 sub-complex (but not Nup98) disengages the HOXA 
gene locus from the nuclear periphery, suggesting a potential role for Nup93 in tethering and repressing the HOXA 
gene cluster. Consistently, Nup93 knockdown increased active histone marks (H3K9ac), decreased repressive histone 
marks (H3K27me3) on the HOXA1 promoter and increased transcription elongation marks (H3K36me3) within the 
HOXA1 gene. Moreover, the combined depletion of Nup93 and CTCF (a known organizer of HOXA gene cluster) but 
not Nup93 alone, significantly increased GLCCI1 gene expression levels. Taken together, this suggests a novel role for 
Nup93 and its interactors in repressing the HOXA gene cluster.
Conclusions: This study reveals that the nucleoporin Nup93 assisted by its interactors Nup188 and Nup205 mediates 
the repression of HOXA gene expression.
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Background
The nuclear pore complex (NPC) is a highly conserved 
protein complex, localized at the nuclear periphery and 
is required for import and export of proteins and RNA [1, 
2]. Nucleoporins in Saccharomyces cerevisiae, Drosophila 
melanogaster and mammalian cells are also involved in 
transcriptional regulation [3–7], transcriptional memory 
[8–10], demarcating chromatin boundaries [11, 12], 
differentiation, development [4, 13–15], DNA dam-
age repair [16, 17] and chromatin organization [18, 19]. 
These functions are likely to involve chromatin contacts 
with nucleoporins. Typically, Nups contact chroma-
tin in either an off-pore or on-pore manner. In humans, 
Nup98 contacts chromatin in an off-pore manner inside 
the nucleoplasm away from the nuclear periphery [13, 
20]. In Drosophila, mobile Nups such as Nup98, Sec13 
and Nup50 re-localize to the nucleoplasm and contact 
chromatin [21]. Nup153 and Megator (Mtor) are mobile 
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nucleoporins that associate with ~25% of the Drosoph-
ila genome at Nucleoporin-associated regions (NARs) 
[22]. In neural progenitor cells, nucleoporins contact 
chromatin in an on-pore manner, for instance a group 
of genes that include GRIK1, NRG1 and MAP2 are spe-
cifically associated with Nup98 at the nuclear envelope 
upon transcriptional activation [13]. The yeast Nup170p 
associates with the RSC chromatin remodeling com-
plex and the silencing factor Sir4p which cooperatively 
mediates the association of telomeres with the nuclear 
envelope resulting in sub-telomeric gene silencing [23]. 
Taken together, these studies suggest an association of 
nucleoporins with chromatin. However, the molecular 
mechanisms of nucleoporins and their interaction with 
chromatin in transcription regulation remain unclear. 
Nucleoporins in addition to their primary role in nuclear 
transport also function in chromatin organization. How-
ever, the mechanisms of chromatin organization medi-
ated by stable and on-pore nucleoporins remain unclear.
The nucleoporin Nup93 sub-complex is composed of 
Nup93, Nup188, Nup205, Nup155 and Nup53 [24–28]. 
Nup93 is a highly stable nucleoporin with a relatively low 
dissociation rate from the nuclear pore complex (Koff: 
4.0 ± 3.4 × 10−6 s−1) [29]. Interestingly, ChIP-chip stud-
ies using tilling microarrays for human chromosomes 5, 7 
and 16 in HeLa cells reveal that Nup93 contacts chroma-
tin sub-domains on these chromosomes [30]. These stud-
ies show an association of Nup93 with the promoters of 
HOXA1, HOXA3 and HOXA5 on human chromosome 7. 
However, the potential role of nucleoporins in regulating 
HOX gene expression is unclear. This raises the intriguing 
possibility of Nup93 to function as an additional modu-
lator of the HOXA chromatin sub-cluster and therefore 
HOXA gene expression during differentiation.
The HOXA gene locus (Chr.7p15.3) spans ~150  kb 
of the sub-genomic region (27,112,593–27,254,038  bp, 
hg19 assembly) and encodes for 11 transcription factors 
that are involved in pattern formation in early develop-
ment [31]. Aberrant HOXA expression levels correlate 
with cancers and is dysregulated in breast carcinoma, 
human cutaneous melanoma and oral cancers [32–37]. 
Chromosome conformation capture studies have shown 
that the repressed HOXA gene cluster adopts a compact 
chromatin state organized as “multiple chromatin loops” 
for instance in undifferentiated NT2/D1 cells [38–40]. 
These loops of the HOXA gene loci are disrupted by the 
combined action of retinoic acid treatment and depletion 
of CTCF or PRC2 that transcriptionally activate HOXA 
gene expression [38].
Brown et  al. [7] showed for the first time that Nup93 
contacts chromatin and associates with the HOXA 
promoter. We extended this study to address the 
consequences of depleting Nup93 on HOXA gene 
expression. We show that Nup93 associates with and 
represses HOXA gene expression in a manner depend-
ent on its interacting partners—Nup188 and Nup205, in 
diploid colorectal cancer cells (DLD1). The depletion of 
Nup93 or its interacting partners—Nup188 and Nup205, 
derepresses the HOXA gene cluster since this showed a 
marked increase in HOXA gene expression, facilitated by 
enhanced levels of the active histone marks (H3K9ac) and 
decreased levels of repressive histone marks (H3K27me3) 
on the HOXA1 promoter. In addition, transcription elon-
gation marks (H3K36me3) were enriched within the 
HOXA1 gene. This is consistent with an untethering of 
the HOXA gene cluster from the nuclear periphery upon 
depletion of Nup93 or its interactors Nup188 or Nup205, 
but not in Nup98-depleted cells. Furthermore, Nup93 
represses HOXA gene cluster independent of its key reg-
ulator, i.e., CTCF [38]. Taken together, this study reveals 
that Nup93 along with its interacting partners—Nup188 
and Nup205, represses HOXA gene expression.
Results
It is well established that chromatin is associated with 
nuclear landmarks such as the nuclear lamina, nucleo-
lus, nuclear bodies and the nuclear pore complex [41, 42]. 
However, the specific structural and functional role of 
these nuclear landmarks in regulating chromatin organi-
zation and gene expression remains elusive [42, 43]. As 
shown previously across biological systems, chromatin 
at the nuclear periphery is directly or indirectly associ-
ated with nuclear pore proteins [44]. Nup93—a scaffold 
nucleoporin at the core of the nuclear pore complex, con-
tacts chromatin sub-domains of human chromosomes 5, 
7 and 16 in HeLa cells as revealed by ChIP-chip studies 
using tilling microarrays for these chromosomes (Fig. 1a) 
[30]. Furthermore, chromosome 7 is predominantly 
localized toward the nuclear periphery [45]. HOXA is an 
important gene cluster that maps to human chromosome 
7 with Nup93 binding sites on HOXA1, HOXA3 and 
HOXA5 gene promoters [30]. The focus of our study was 
to examine the consequences of depleting Nup93 and its 
interactors on HOXA gene expression in diploid colo-
rectal cancer cells (DLD1). The DLD1 cell line is a colo-
rectal adenocarcinoma cell line which maintains a stable 
and near diploid karyotype with a modal number of 46 
chromosomes.
Nup93 associates with HOXA promoter regions
Chromatin immunoprecipitation on chip in HeLa cells 
showed that Nup93 binds to the promoter regions 
[~1000 bp upstream of the transcription start site (TSS)] 
of HOXA1, HOXA3 and HOXA5 on human Chr.7p15.2 
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[30]. To validate the antibody that we used against Nup93, 
we performed immunoprecipitation assays, which 
detected a single band at ~93 kDa (Fig. 1b). Furthermore, 
siRNA-mediated knockdown followed by immunoblot-
ting, showed a >70% depletion of Nup93 (Fig. 1c), thereby 
validating this antibody for ChIP experiments. In order 
to ascertain if Nup93 associates with the HOXA pro-
moter region and to extend earlier observations, we per-
formed ChIP-qPCR of specific subregions of the HOXA 
promoter [30] (Fig. 1d). We found that Nup93 was indeed 
enriched on specific subregions of HOXA1, HOXA3 
and HOXA5 promoters (Fig.  1d, e), which further vali-
dated that Nup93 associates with the HOXA1, HOXA3, 
and HOXA5 promoter sequences, respectively (Fig.  1e). 
Nup93 was not enriched on GLCCI1 promoter—a gene 
locus ~19  Mb upstream of HOXA1 on Chr.7p21.3, 
and therefore served as a negative control (Fig.  1e-iv) 
[30]. To further validate the association of Nup93 with 
HOXA promoter regions, we performed ChIP-qPCR 
with Nup93 in Nup93-depleted cells. ChIP-qPCR results 
showed a significantly reduced association of Nup93 with 
the HOXA1 promoter upon Nup93 knockdown (Fig. 1f ). 
To ascertain the binding preferences of Nup93, we exam-
ined whether Nup93 associates with regions outside the 
HOXA1 promoter (~3  Kbp upstream and downstream 
of the HOXA1 promoter region) (Fig.  1d) and another 
Nup93 target gene (GRM8) (Chr.7q31.11). Nup93 asso-
ciates within the GRM8 gene body but not with its pro-
moter [30]. We found that Nup93 does not associate 
with sites just outside the HOXA1 promoter (~3  Kbp) 
(Fig.  1g). In contrast, Nup93 was significantly enriched 
within the GRM8 gene (Fig.  1g). We reconfirmed our 
results by performing ChIP-PCR using primer pairs 
P3, P4, P2 and P4 for HOXA1, HOXA3, HOXA5 and 
GLCCI1 respectively (Fig. 1h).  In summary, these results 
corroborate the association of Nup93 with the HOXA1, 
HOXA3 and HOXA5 promoter regions.
Nup93 requires its interactors Nup188 and Nup205 
to associate with the HOXA1 promoter
We sought to determine whether the interactors of 
Nup93, i.e., Nup188 and Nup205 [46] are required for 
Nup93 to associate with the HOXA1 promoter region. 
We ascertained if Nup93 interacts with Nup188 and 
Nup205. Co-immunoprecipitation of Nup93 from whole-
cell extracts of DLD1 cells showed that Nup93 interacts 
with Nup188 and Nup205, respectively (Fig.  2a, b) [46, 
47]. However, Nup93 does not associate with Nup98 and 
neither did we detect an association between Nup188 
and Nup98 (Fig. 2a, b), consistent with previous findings 
that Nup98 does not interact with Nup93 [46]. Reverse 
co-immunoprecipitation showed that Nup188 associ-
ates with Nup93 but not with Nup205 or Nup98 (Fig. 2b). 
Furthermore, Co-IP studies showed a reduced interac-
tion of Nup93 with Nup188 in Nup205-depleted cells, 
suggesting the requirement for Nup205 in the interaction 
between Nup93 and Nup188 (Additional file 1: Fig. S1a). 
Taken together, these results suggest that Nup93 associ-
ates with Nup188 and Nup205 consistent with co-immu-
noprecipitation assays performed in C. elegans and S. 
cerevisiae, which show that Nup93 interacts with nucleo-
porins—Nup188 and Nup205 [26, 27, 46–48].
We determined whether the interactors of Nup93, 
i.e., Nup188 and Nup205 are required for Nup93 to 
associate with the HOXA1 promoter region (Fig.  2d). 
We performed ChIP with Nup93, in a background of 
Nup188- or Nup205-depleted DLD1 cells (Fig.  2c). 
ChIP-PCR and chip-qPCR performed on HOXA1 pro-
moter region (Region P3, Fig.  1d, e–i) showed that 
Nup188 and Nup205 depletion decreased the occupancy 
of Nup93 by ~70% on the HOXA1 promoter (Fig. 2d and 
Additional file  1: Fig. S1b). However, the occupancy of 
the core histone H3 (ChIP with anti-PanH3 antibody 
that detects core histone H3) was unaltered on either 
HOXA1 or GLCCI1 promoters upon Nup188 or Nup205 
(See figure on next page.)  
Fig. 1 Nup93 associates with HOXA1, HOXA3 and HOXA5 promoters. a Pictorial representation of the nuclear pore complex (NPC) showing the 
relative location of the Nup93 sub-complex, and Nup98 within the nuclear pore complex [103]. b Immunoprecipitation of Nup93 using anti-Nup93 
antibody on whole-cell extracts of DLD1 cells (a representative full blot from three independent biological replicates, N = 3). Anti-rabbit heavy 
chain IgG shows equal precipitation efficiency in IgG and Nup93 lanes. c A representative full Western blot showing siRNA-mediated depletion of 
Nup93 in DLD1 cells (lane Nup93 Kd), Untreated Untreated cells, siNeg ON-TARGETplus non-targeting siRNA control (a representative blot from three 
independent biological replicates, N = 3). d Pictorial representation of primer pair positions (P1–P4) on the promoter of HOXA1, HOXA3 and HOXA5 
genes, respectively, upstream region and downstream region indicates primer position outside the HOXA1 promoter, arrow indicates transcription 
start site (TSS). e ChIP experiments were performed using antibodies specific to Nup93 and IgG control. Nup93 ChIP-qPCR on (i) HOXA1 (ii) HOXA3 
(iii) HOXA5 and (iv) GLCCI1 promoters, respectively. Y-axis: immunoprecipitated DNA relative to 1% input, corrected for ChIP using non-specific 
IgG (N = 2, data from two independent biological replicates that include a total of six technical replicates), error bar standard error of mean (SEM). 
f Nup93 ChIP-qPCR was performed in untreated and Nup93 knockdown cells for HOXA1 promoter using primer pairs P1–P4. g Nup93 ChIP-qPCR 
using primer pairs outside HOXA1 promoter regions (upstream region and downstream region) and primers for a Nup93-associated gene (GRM8), 
used as a positive control. h ChIP-PCR amplification of HOXA1, HOXA3 and HOXA5. GLCCI1 used as negative control. Nup93 binds to ~300–600 bp 
on each of these HOXA promoters, (N = 2, representative data from two independent biological replicates)
Page 4 of 21Labade et al. Epigenetics & Chromatin  (2016) 9:54 
Page 5 of 21Labade et al. Epigenetics & Chromatin  (2016) 9:54 
Page 6 of 21Labade et al. Epigenetics & Chromatin  (2016) 9:54 
depletion (Additional file 1: Fig. S1b–c). Although inde-
pendent knockdowns of Nup93, Nup188 and Nup205 
did not affect the transcript levels of one another (Addi-
tional file  1: Fig. S1d), we detected a decrease in their 
relative protein levels in an interdependent manner 
(Fig.  2e and Additional file 1: Fig. S1f–g). We therefore 
considered the possibility that the reduced occupancy of 
Nup93 on HOXA1 could be attributed to reduced lev-
els of Nup93 in cells depleted of Nup188 or Nup205. To 
account for the decrease in the levels of Nup93 upon 
Nup188 or Nup205 depletion, we overexpressed Nup93 
in a background of Nup188 or Nup205 depletion (Fig. 2f, 
g). Despite Nup93 overexpression (Fig. 2f, g, Additional 
file 1: Fig. S1e), Nup93 showed a reduced occupancy on 
the HOXA1 promoter in either Nup188- or Nup205-
depleted cells (Fig.  2h, i). This suggests that overex-
pressed Nup93 is unable to associate with the HOXA1 
promoter in the absence of Nup188 or Nup205. Taken 
together, these results suggest that a stable complex of 
Nup188–Nup93–Nup205 is required for Nup93 to asso-
ciate with the HOXA1 promoter.
HOXA gene expression is upregulated in Nup93‑, Nup188‑ 
or Nup205‑depleted cells
The finding that Nup93 associates with the promot-
ers of HOXA1, HOXA3 and HOXA5 genes assisted 
by Nup188 and Nup205 (Figs.  1e, 2d) prompted us to 
investigate whether Nup93 and its interactors regulate 
HOXA gene expression. We independently knocked 
down Nup93, Nup188 and Nup205 in DLD1 cells and 
assessed expression levels of all genes within the HOXA 
gene cluster (HOXA1–HOXA13) by qRT-PCR (Fig. 3a–
c). Nup93, Nup188 and Nup205 knockdown showed 
a >80% reduction in their transcript levels (Fig.  3a–c, 
arrow). Remarkably, the transcript levels of HOXA genes 
(HOXA1, HOXA3, HOXA5 and HOXA9) were strik-
ingly upregulated (fold change >twofold) upon Nup93 Kd 
(Fig. 3a). HOXA1 showed an increase in transcript levels 
in all three nucleoporin knockdowns to ~four–sixfold, 
suggesting a significantly greater impact on HOXA1 
expression levels upon Nup93, Nup188 and Nup205 
knockdowns. Furthermore, HOXA1, HOXA3, HOXA5 
and HOXA9 were significantly upregulated in Nup188- 
and Nup205-depleted cells (Fig.  3b, c). Interestingly, 
the expression levels of HOXA13 and GLCCI1 were 
unaffected in all the three Nup knockdowns (HOXA13, 
GLCCI1, Fig.  3a–c). We also used two independent 
siRNA oligonucleotides to knockdown Nup93 (Addi-
tional file 2: Fig. S2a), which showed an upregulation of 
HOXA1, HOXA3, HOXA5 and HOXA9 genes but not 
of HOXA13 or GLCCI1 (Fig. S2b), consistent with pre-
vious results (Fig.  3a). Of note, the depletion of Nup98 
did not alter gene expression levels of the HOXA gene 
cluster and GLCC1 (Additional file  2: Fig.  S2b), further 
suggesting a novel role for Nup93 and its interacting 
partners—Nup188 and Nup205, in regulating HOXA 
gene expression in DLD1 cells.
Since ChIP showed a reduced occupancy of Nup93 on 
the HOXA1 promoter despite Nup93 overexpression in 
Nup188- and Nup205-depleted cells (Fig. 2h, i), we deter-
mined the effect of Nup93 overexpression on HOXA 
transcript levels in Nup188- and Nup205-depleted cells, 
respectively. Interestingly, Nup93 overexpression was 
incapable of rescuing HOXA gene expression in Nup188- 
and Nup205-depleted cells (Fig.  3d, e, Additional file  1: 
Fig. S1e). Taken together, these assays further reiterate 
a requirement for Nup188 and Nup205 in Nup93-medi-
ated repression of HOXA gene expression.
We were curious to examine the consequences of 
allowing cells to recover after Nup93 depletion and 
asked whether the upregulation of HOXA gene expres-
sion was reversible or irreversible, since an irreversible 
upregulation of HOXA may imply a feedback effect to 
sustain HOXA upregulation. We allowed cells to recover 
in culture for 8  days after 48  h of Nup93, Nup188 and 
Nup205 knockdown in DLD1 cells. Interestingly, we 
detected a significant restoration in the transcript levels 
of Nup93, Nup188 and Nup205, respectively (Additional 
(See figure on previous page.) 
Fig. 2 Nup93 interacts with Nup188 and Nup205 and associates with the HOXA1 promoter. a, b Immunoprecipitation was performed using 
antibodies specific for (a) Nup93; (b) Nup188 and IgG followed by Western blotting for Nup93, Nup188, Nup205 and negative control—Nup98 
(representative data from three independent biological replicates, N = 3, single experiment for Nup98). c (i) Nup188 and (ii) Nup205 were knocked 
down in DLD1 cells using siRNA. A representative Western blot showing the extent of knockdown (representative Western blot from three inde-
pendent biological replicates, N = 3). d ChIP experiment was performed using an anti-Nup93 antibody in untreated, non-targeting siRNA control 
(siNeg), Nup188 Kd (Knockdown) and Nup205 Kd cells. ChIP-qPCR analysis was used to determine the extent of Nup93 association with the HOXA1 
promoter in Nup188 and Nup205 knockdown cells (Input and PanH3 in Fig. 2d are from Nup205 Kd sample) Y-axis: immunoprecipitated DNA rela-
tive to 1% input, corrected for ChIP using non-specific IgG (N = 2, data from two independent biological replicates that include a total of six techni-
cal replicates), error bar: standard error of mean (SEM). e A representative Western blot showing the effect of Nup93, Nup188 and Nup205 depletion 
on one another (three independent biological replicates, N = 3), f, g a representative Western blot showing overexpression of Nup93 upon Nup188 
(f) and Nup205 knockdown (g). GAPDH was used as a loading control. h, i ChIP-qPCR was performed upon overexpression of (f) Nup93 in Nup188- 
and (g) Nup205-depleted cells. Y-axis: immunoprecipitated DNA relative to 1% input, corrected for ChIP using non-specific IgG (N = 2, data from 
two independent biological replicates that include a total of six technical replicates), error bar: standard error of mean (SEM)
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Fig. 3 Depletion of Nup93, Nup188 and Nup205 derepresses HOXA gene cluster. a–c qRT-PCR analyses was used to determine mRNA levels of all 
HOXA genes (HOXA1 to HOXA13) upon (a) Nup93, (b) Nup188 and (c) Nup205 knockdowns in DLD1 cells. Graph represents fold change (2−Ct) in 
levels of mRNA normalized to untreated cells. Error bars: SEM, data from three independent biological replicates that include total of nine technical 
replicates, *p < 0.05; **p < 0.01; ***p < 0.001 (Students t test between siNeg and knockdown). GLCCI, served as a negative control. d ,e qRT-PCR 
analyses was used to determine mRNA levels of all HOXA genes (HOXA1 to HOXA13) upon Nup93 overexpression in (d) Nup188- and (e) Nup205-
depleted cells. Graph represents fold change (2−Ct) in levels of mRNA normalized to untreated cells. Error bars: SEM, data from two independent 
biological replicates that include total of six technical replicates. GLCCI, served as a negative control
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file  2: Fig. S2c–e) accompanied by the downregulation 
of HOXA1 and HOX9 transcript levels, while HOXA13 
levels remained unaltered (Additional file 2: Fig. S2c–e). 
Taken together, these results uncover a novel role for 
Nup93 and its interacting partners in the repression of 
the HOXA gene cluster.
HOXA gene loci is untethered from the nuclear periphery 
in Nup93‑, Nup188‑ and Nup205‑depleted cells
The significant upregulation of HOXA genes upon 
Nup93, Nup188 and Nup205 depletion prompted us 
to determine the spatial localization of HOXA gene 
locus upon Nup93, Nup188 or Nup205 depletion 
in the interphase nucleus. Gene loci tethered to the 
nuclear periphery are typically maintained in a state 
of repression [49]. We performed three-dimensional 
fluorescence in  situ hybridization (3D-FISH) followed 
by confocal imaging of fluorescently labeled HOXA 
gene locus and Chromosome 7 Territories (CT7) in 
cells independently depleted of Nup93, Nup188 and 
Nup205, respectively (Fig. 4a). We measured the short-
est distance of the HOXA gene locus from the nuclear 
periphery [50]. HOXA gene loci were predominantly 
localized closer to the nuclear periphery in control 
cells [median = 0.64 µm from the edge of the nucleus 
in control cells (Fig.  4b, c)]. Interestingly, Nup93-, 
Nup188- or Nup205-depleted cells showed an ~0.2-
µm shift of the HOXA gene loci away from the nuclear 
edge (Fig. 4b, c). In contrast, Nup98 depletion did not 
affect the positioning of the HOXA loci with respect 
to the nuclear periphery (Fig.  4b, c). Taken together, 
this suggests that Nup93 and its interactors are likely 
to tether the HOXA gene locus closer to the nuclear 
periphery in order to maintain HOXA gene locus in a 
repressed configuration, while depletion of Nup93 or 
either of its interacting partners results in a movement 
of the HOXA gene locus toward the nuclear interior 
(Fig. 4c).
Nup93 depletion alters the relative occupancy of histone 
marks on the HOXA1 promoter
We determined whether the observed derepression 
of the HOXA gene cluster upon Nup93 depletion is 
associated with an altered occupancy of active and inac-
tive histone marks on the HOXA1 promoter region 
(Fig. 5a). We performed ChIP with active (H3K9ac) and 
repressive (H3K27me3) histone marks on the HOXA1 
promoter in Nup93-depleted cells (Fig.  5b–e). We 
determined the levels of active and repressive histone 
marks on the HOXA1 promoter upon Nup93 knock-
down, since HOXA1 showed the highest increase in 
transcript levels (>four–sixfold) in cells depleted of 
Nup93 or its interacting partners—Nup188 or Nup205 
(Fig. 3a–c). We performed ChIP with antibodies against 
active (H3K9ac) and repressive (H3K27me3) histone 
marks followed by ChIP-qPCR with overlapping prim-
ers ~1  Kb upstream of the HOXA1 transcription start 
site (Fig.  5a). We detected a significant enrichment of 
the active histone mark (H3K9ac), ~1  Kb upstream of 
the transcription start site of the HOXA1 gene (Fig. 5b) 
and a marked decrease in the occupancy of the repres-
sive histone mark (H3K27me3) upon Nup93 knock-
down (Fig. 5c). Notably, the relative levels of active and 
repressive histone marks were unaltered upon Nup93 
depletion on the promoters of control genes—GAPDH 
and GLCCI1 (Fig. 5d, e). Furthermore, the total levels of 
H3K9ac, H3K27me3 and PanH3 were unaffected upon 
Nup93 depletion in DLD1 cells (Fig. 5f ). Taken together, 
these results suggest a strong correlation between 
Nup93 depletion and the relative enrichment of the 
active histone mark and decreased occupancy of the 
inactive histone mark on the HOXA1 promoter. This is 
consistent with previous studies which show that silenc-
ing of the HOXA gene cluster is mediated by Polycomb 
(PcG) proteins by the recruitment of repressive histone 
marks (H3K27me3) on the HOXA gene promoter of 
NT2/D1 embryonal carcinoma cell line and in HeLa 
cells [38, 51].
Since we detected a striking increase in the expres-
sion levels of the HOXA1 gene upon Nup93, Nup188 
and Nup205 knockdown, we asked whether HOXA1 
gene expression correlates with active transcriptional 
elongation, i.e., active transcription of the HOXA1 gene. 
We performed ChIP with H3K36me3—a histone mark 
enriched during transcriptional elongation [52], with the 
HOXA1 gene (Fig. 5a). Interestingly, Nup93 knockdown 
(See figure on next page.)  
Fig. 4 HOXA gene loci is untethered from the nuclear periphery upon Nup93, Nup188 and Nup205 depletion. a Representative images (maximum 
intensity projection of a confocal image stack) of 3D-FISH for HOXA (red), CT7 (green) and DAPI (blue) performed on siLacZ-, Nup93-, Nup188-, 
Nup205- and Nup98-depleted DLD1 cells. Scale bar ~10 μm, white dotted line indicates nuclear boundary. b Dot scatter plot showing shortest 
distance of HOXA gene locus from nuclear periphery demarcated by DAPI in siLacZ (n = 164 loci signals)-, Nup93 (n = 154)-, Nup188 (n = 178)-, 
Nup205 (n = 178)- and Nup98 (n = 124)-depleted DLD1 cells, horizontal bar represents median with interquartile range. Data from two independ-
ent biological replicates, **p < 0.01; ****p < 0.001 (Kolmogorov–Smirnov test). c % Frequency distribution profile of HOXA gene locus from nuclear 
periphery plotted as bins of ~0.2 µm each from the nuclear periphery. Y-axis represents % frequency of HOXA locus pooled from two independent 
biological replicates
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Fig. 5 Nup93 depletion alters the occupancy of histone marks on HOXA1 promoter. a Pictorial representation of the HOXA1 promoter and regions 
within the HOXA1 gene (Region 1–Region 3). Left (light gray) promoter of HOXA1 gene, double arrowheads: overlapping primer positions on HOXA1 
promoter. Right (dark gray) regions within HOXA1 gene, double arrowheads: ChIP-qPCR primer positions within HOXA1 gene (Region 1–Region 3). 
b, c ChIP experiments were performed using antibodies specific to (b) H3K9ac, (c) H3K27me3 and IgG in untreated, siNeg and Nup93 knockdown 
cells (IgG is below detection limit <0.2% of input in ‘b–d’, re-plotted in Additional file 2: Fig. S2h–j), d, e GAPDH promoter and GLCCI1 promoter were 
used as positive and negative controls, respectively. Y-axis: immunoprecipitated DNA is relative to 1% input, corrected for ChIP using non-specific 
IgG (data from two independent biological replicates that include a total of six technical replicates), error bars: SEM. f Representative Western blot 
of untreated, siNeg and Nup93 Kd cells showing that total levels of H3K9ac and H3K27me3 are unaltered. PanH3 and Tubulin were used as loading 
controls (data from a single experiment). g Elongation mark (H3K36me3) shows increased occupancy on the HOXA1 gene (Region 1, Region 2 and 
Region 3), data from two independent biological replicates that include a total of six technical replicates, error bars: SEM, Nup93 knockdown alters 
occupancy of histone marks on HOXA1 promoter
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Fig. 6 Nup93 depletion reduces nuclear import but does not affect nuclear export. a A representative image of nuclear import assay performed 
using GR2-GFP2-M9 construct transfected in cells treated independently with LacZ and siNup93. To induce nuclear import of GR2-GFP2-M9 fusion 
protein, cells were treated with dexamethasone (Dex) (5 µM) for 30 min, white arrowhead indicates absence of cytoplasmic GFP in LacZ + Dex 
and residual cytoplasmic GFP in Nup93 Kd + Dex. Scale bar ~10 µm. b A representative image of Poly(A) RNA FISH performed using FAM-labeled 
oligo(dT) probe (green) in siNeg, Nup93 Kd, Nup188 Kd, Nup205 Kd and Nup98 Kd, scale bar ~10 µm, white arrowhead indicates Poly(A) RNA foci in 
the nucleus. Nuclear boundary is marked by dotted line in enlarged panel. Nup98 enlarged panel shows both nuclear and cell boundary with white 
dotted line. c Nuclear/cytoplasmic (N/C) ratio of GR2-GFP2-M9 was determined by quantifying its relative fluorescence intensity in the nucleus 
and cytoplasm. Scatter plot of GFP signals expressed as nuclear-to-cytoplasmic ratios from LacZ (n = 60 cells), Nup93 Kd (n = 57), Nup188 Kd 
(n = 60), Nup205 Kd (n = 59) and Nup98 Kd (n = 60), data from 2 independent biological replicates (****p < 0.0001). d Poly(A) RNA distribution 
was determined by quantifying its fluorescence intensity in the nucleus and cytoplasm. Scatter plot of Poly(A) signals expressed as nuclear (N)-to-
cytoplasmic (C) ratios from siNeg (n = 127 cells), Nup93 Kd (n = 158), Nup188 Kd (n = 288), Nup205 Kd (n = 288); N/C ratio was not significant (ns) 
when compared to siNeg (p > 0.05), while Nup98 Kd (n = 97) shows a relatively higher nuclear-to-cytoplasmic ratio (N/C ratio) of Poly(A) signals 
(***p = 0.0017). Two independent biological replicates for siNeg, Nup93 Kd and Nup98 Kd. Data from a single experiment for Nup188 Kd and 
Nup205 Kd. Horizontal line represents median, p values obtained from Mann–Whitney U test. Nuclear transport of Poly(A) RNA was unaffected in 
Nup93-, Nup188- or Nup205- depleted cells
showed a specific enrichment of H3K36me3 on all three 
regions (Region 1–Region 3) within the HOXA1 gene 
(Fig. 5g). Taken together, these experiments strongly sug-
gest that active transcription of the HOXA1 gene upon 
depletion of Nup93 is associated with an increased occu-
pancy of active histone marks and decreased levels of 
repressive histone marks.
Nup93 depletion reduces nuclear import but does not 
affect nuclear export
In order to address the role of Nup93 and its interactors 
in HOXA gene expression, we were curious to deter-
mine whether nuclear transport was affected in cells 
depleted of Nup93 or either of its interactors Nup188 or 
Nup205. To determine the effect of Nup93 depletion on 
nuclear import, we transfected DLD1 cells with a dexa-
methasone-inducible reporter construct consisting of 
the hormone-responsive domain of glucocorticoid and 
GFP fused to the M9 core domain (GR2-GFP2-M9core) 
[53]. Upon transient transfection, the reporter construct 
was exclusively localized in the cytoplasm, which trans-
located to the nucleus within 30 min in the presence of 
5  µM dexamethasone (glucocorticoid hormone ana-
logue) in control cells (LacZ, Fig.  6a and c, Additional 
file  3: Fig. S3). Nup93, Nup188 or Nup205 depletion 
showed a reduced nuclear import of the reporter GFP 
construct as compared to control cells after 30  min of 
dexamethasone addition (Fig. 6a, c, Additional file 3: Fig. 
S3). Notably, Nup98 depletion blocked nuclear import of 
the reporter GFP (Fig. 6c and Additional file 3: Fig. S3). 
Taken together, this suggests that the depletion of Nup93 
or its interactors results in reduced nuclear import.
As a readout of nuclear export, we examined the nucle-
ocytoplasmic distribution of fluorescently labeled Poly(A) 
RNA in Nup93-, Nup188- or Nup205-depleted cells 
(Fig. 6b, d), since Poly(A) RNA is abundant in cells and is 
typically associated with mature transcripts [54]. Poly(A) 
RNA is detectable within the nucleus as foci (Fig.  6b) 
and diffusely within the cytoplasm (Fig. 6b, siNeg panel). 
We did not detect a significantly altered distribution of 
Poly(A) signals inside or outside the nucleus in Nup93-, 
Nup188- or Nup205-depleted cells, as compared to 
control cells (siNeg, Fig.  6b, d, Additional file  4: Fig. 
S4). This is consistent with a normal nuclear export in 
nuclear reassembly assays performed in Nup188–Nup93 
immunodepleted Xenopus egg extracts [46]. Depletion 
of Nup98—an established regulator of nuclear export, 
showed a retention of Poly(A) RNA in the nucleus, evi-
denced by a significant increase in the nuclear-to-cyto-
plasmic ratio of Poly(A) RNA in DLD1 cells (Fig.  6b, 
d) [55–57]. Taken together, these assays suggest that, 
although nuclear export was not significantly affected, 
nuclear import was reduced but not inhibited in cells 
depleted of Nup93 or its interacting partners.
HOXA derepression upon Nup93 depletion is independent 
of CTCF
CTCF and PRC2 complex proteins regulate chroma-
tin looping and expression of the HOXA gene cluster in 
embryonic stem cells [31, 38, 39, 51, 58–60]. We sought 
to ask whether CTCF regulates HOXA gene expression 
levels. We determined whether CTCF and PRC2 complex 
proteins associate with Nup93 (Fig. 7a, b). Co-immuno-
precipitation (Co-IP) assays did not reveal an association 
between Nup93 and CTCF (Fig. 7a), or between Nup93 
and PRC2 complex proteins (EED or Suz12) in DLD1 
cells (Fig. 7b). Furthermore, levels of CTCF or the PRC2 
complex proteins (EZH2, Suz12 and EED) were unaltered 
in Nup93-, Nup188- or Nup205-depleted cells (Fig.  7c). 
CTCF is a known organizer of the HOXA gene cluster 
and has conserved binding sites that are proximal to the 
5’ region of the HOXA gene cluster which do not over-
lap with Nup93 binding sites (Fig. 7e) [38]. We therefore 
investigated the effect of CTCF depletion on HOXA gene 
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expression, by knocking down CTCF alone and in combi-
nation with Nup93 (Fig.  7f ). Interestingly, the depletion 
of CTCF alone did not affect gene expression levels of 
any of the genes within the HOXA gene cluster (Fig. 7f, 
gray bars). In contrast, CTCF depletion significantly 
upregulated the transcript levels of GLCCI1—a gene 
otherwise unaffected upon Nup93 knockdown (Fig.  7f, 
GLCCI1). This is consistent with the role of CTCF in 
regulating the organization of topologically associated 
domains (TADs), the disruption of which potentially 
impact distant genomic regions [61]. Notably, the com-
bined knockdown of both CTCF and Nup93 upregulated 
expression levels of HOXA genes, comparable to Nup93 
knockdown alone (Fig.  7f, compare green and orange 
bars). Of note, GLCCI1 showed an enhanced upregula-
tion in Nup93  +  CTCF Kd cells, suggesting an altered 
regulatory role for CTCF in cells subjected to a com-
bined depletion of Nup93 and CTCF. Taken together, we 
conclude from these assays that Nup93 and CTCF may 
have complementary functions in the organization of the 
HOXA gene cluster.
Discussion
The regulated expression of the HOX family of transcrip-
tion factors is required during early development and 
differentiation, whereas its untimely expression in differ-
entiated cells is associated with disease [33, 34, 37, 62]. 
HOX gene expression is also maintained in differenti-
ated cells such as human skin fibroblasts in a manner that 
retains their tissue-specific origin [63]. ChIP-chip studies 
using tiling microarrays revealed an association of Nup93 
with human chromosomes 5, 7 and 16 [30]. Nup93 was 
enriched on the HOXA sub-cluster of human chromo-
some 7 [30]. Here, we show that Nup93 associates with 
the HOXA gene cluster in a manner dependent on its 
interactors Nup188 and Nup205. Furthermore, depletion 
of these nucleoporins showed a significant increase in the 
expression levels of HOXA genes. This was consistent 
with a disengagement of the HOXA gene locus from the 
nuclear periphery in Nup93-/Nup188-/Nup205-depleted 
cells. In addition, the upregulation of HOXA genes upon 
Nup93 depletion was associated with an increase in 
active histone marks, reduced inactive marks and enrich-
ment of a transcription elongation mark.
Implications of the association of nucleoporins 
with chromatin
Several studies across organisms have consistently shown 
an association of the mobile nucleoporins such as Nup98, 
Nup50 and Nup153 with chromatin in addition to regu-
lating nuclear transport [3, 6, 9, 13, 15, 22, 23]. We cor-
roborated previous findings of Brown et  al. [30] and 
show that Nup93 indeed associates with the promoters of 
HOXA1, HOXA3 and HOXA5 and represses HOXA gene 
expression (Fig.  3a–c). It is conceivable that the repres-
sive mechanism of Nup93 could potentially extend to 
other HOX gene clusters such as the HOXB, HOXC and 
HOXD, respectively. Chromatin conformation capture 
assays (such as 5C) have shown that the silenced HOXA 
gene cluster adopts a folded loop structure in a human 
myeloid leukemia cell line THP1 [64]. We speculate that 
nucleoporins such as Nup93 may further modulate the 
local three-dimensional organization of the topologically 
associated domains (TADs) within the HOX gene cluster 
[65]. Our studies provide evidence to the growing body 
of literature which reinforce the role of nucleoporins in 
regulating chromatin organization and gene expression. 
Gene expression regulation is typically accompanied by 
an altered occupancy of active and inactive histone marks 
on gene promoters [66, 67]. The active state of the HOXA 
gene cluster is marked by active histone marks such as 
H3K9ac and H3K4me3, while the inactive state shows 
an enrichment of inactive marks such as H3K9me3 and 
H3K27me3 [36, 66, 68]. For instance, histone deacety-
lases and PRC2 complex proteins modify levels of active 
and inactive histone marks on the HOXA gene cluster in 
NT2/D1 embryonal carcinoma cells [38]. Interestingly, a 
recent Dam-ID study showed that Nup93 associates with 
chromatin at the nuclear periphery [69]. Considering 
the localization of the HOXA gene cluster on the gene 
(See figure on previous page.)  
Fig. 7 HOXA is upregulated upon Nup93 depletion independent of CTCF. a Co-immunoprecipitation was performed using anti-Nup93 antibody 
and negative control IgG followed by Western blotting for CTCF, Nup205, Nup188 and Nup93 (data from two independent biological replicates, 
N = 2), b Co-IP for Nup93 and Western blot for Nup93, Nup188, Nup205 (data from three independent biological replicates, N = 3), PRC2 complex 
proteins EED and Suz12 (data from a single experiment). c Representative Western blot showing the levels of Nup93, Nup188, Nup205, Nup98, 
EZH2, Suz12, CTCF, EED upon Nup93, Nup188 and Nup205 Kd (data from a single experiment). d Representative Western blot showing siRNA-
mediated knockdown of CTCF in DLD1 cells. e Epigenome Browser view of CTCF (GSM749729) (arrow indicates potential binding sites of Nup93) 
on HOXA gene cluster. f qRT-PCR analysis was used to determine mRNA levels of all HOXA genes (HOXA1 to HOXA13) upon CTCF and combined 
Nup93 + CTCF knockdowns in DLD1 cells. Graph represents fold change (2−Ct) in levels of mRNA normalized to untreated cells. Error bars SEM, 
data from two independent biological replicates (N = 2) that includes total of 6 technical replicates, GLCCI, served as control. Nup93 Kd data (green 
bars) is from Fig. 3a, plotted here for comparison between Nup93 Kd with Nup93 + CTCF Kd (orange bars). Nup93 does not interact with CTCF or 
PRC2 complex proteins. Nup93 Kd upregulates HOXA gene expression independent of CTCF. CTCF depletion alone upregulates GLCCI1, which is 
unaffected upon Nup93 knockdown
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poor chromosome 7 territory, proximal to the nuclear 
periphery, we found a sequestration of the HOXA gene 
cluster to the nuclear periphery potentially mediated by 
the Nup93 sub-complex but not Nup98 (Fig. 4). We sur-
mise that the depletion of Nup93, Nup188 or Nup205 
and their reduced stability, enhances the accessibility of 
the HOXA gene cluster to transcriptional activators and 
epigenetic modulators that could facilitate their untimely 
expression of HOXA genes—the physiological ramifica-
tions of which remain unclear.
Role of nucleoporins in nuclear transport and chromatin 
organization
Nucleoporins regulate nuclear import and export of 
mRNA, RNA and proteins [1]. In addition, an increasing 
number of evidences implicate nucleoporins in gene reg-
ulation [4, 69–75]. Furthermore, the composition of the 
nuclear pore complex (NPC) is variable across cells types, 
which interestingly has limited effect on nuclear trans-
port [14]. In embryonic stem cells, Nup210 is absent but 
is specifically incorporated into the NPC during differ-
entiation [14]. Dam-ID studies reveal that Nup153 regu-
lates expression of cell identity genes independent of its 
role in nuclear transport [69]. Nup98 is involved in both 
nucleocytoplasmic transport and gene regulation [3, 13, 
76, 77], since Nup98 interacts with the mRNA export fac-
tor Rae1 and regulates mRNA export [57]. Nup98 asso-
ciates with developmentally active genes such as GRIK1, 
ERBB4, NRG1 and DCC and regulates their expression 
levels during differentiation [13]. The Nup98-HOXA9 
fusion protein associates with and inappropriately acti-
vates the HOX gene cluster in mouse embryonic stem 
cells in a manner dependent on the Crm1 protein [78]. 
Interestingly, Nup98 depletion in DLD1 cells did not alter 
either the spatial localization or the expression levels of 
the HOXA gene (Fig.  4 and Fig. S2b), notwithstanding 
its impact on nuclear transport (Fig. 6). This suggests an 
independent role for Nup98 in regulating nuclear trans-
port but not HOXA gene expression. However, in cells 
depleted of Nup93, Nup188 or Nup205, nuclear export 
was relatively unaffected although nuclear import was 
reduced (Fig.  6a). Taken together, these findings impli-
cate nucleoporins such as Nup93, Nup188 and Nup205 
as modulators of chromatin organization in addition to 
their nuclear transport functions.
Potential mechanisms of nucleoporin–chromatin 
interactions
The mechanisms by which core nucleoporins associ-
ate with DNA are unclear. More importantly, several 
findings suggest that nucleoporins are involved in chro-
matin remodeling owing to their association with chro-
matin modifiers such as the SAGA complex, HDACs, 
RSC complex, SUMO proteases, SENP1, SENP2 and 
MSL complex [23, 77, 79–82]. Chromatin remodeling 
complexes such as the SAGA complex—a transcriptional 
activator, associates with the nuclear pore complex and 
activates HXK1, INO1 and GAL genes when recruited to 
the NPC [5, 10, 83–87]. Nup2, Nup60, Nic96, Nup116, 
Mlp1 and Mlp2 are enriched on transcriptionally active 
regions in S. cerevisiae [85, 88]. Furthermore, ARP6 
links the active housekeeping gene RPP1A, involved 
in ribosome biogenesis to the nuclear pore complex 
[89]. Nup170p represses ribosomal biogenesis genes 
and genes on the sub-telomeric region [23, 89]. Nup120 
and Nup133 also core nucleoporins repress SUC2 gene 
expression in yeast [90]. Interestingly, Nup93 tethers and 
regulates the expression of cell identity genes, predomi-
nantly localized at the nuclear periphery [69]. The tether-
ing of HOXA gene cluster to the nuclear periphery and 
its repression by the Nup93 sub-complex adds to the rep-
ertoire of nucleoporin-mediated gene repression events 
(Fig. 4). Analyses of protein–protein interaction networks 
using BIOGRID [91] of human Nup93 shows that Nup93 
interacts with chromatin modifiers such as HDAC11, 
HDAC9, HDAC5 and PCR2 complex proteins—EED and 
Suz12. It is conceivable that Nup93 and its interactors 
associate with transcriptional repressors in repressing the 
HOXA gene cluster, although we did not detect a direct 
association between Nup93 and the chromatin repres-
sive complex (PRC2) (Fig. 7b). ChIP-mass spectrometric 
approaches may identify putative interactors of Nup93 
involved in chromatin organization.
Nucleoporins as repressors of HOXA gene expression 
independent of CTCF
Regulation of HOXA gene expression is essential during 
early development, since the aberrant expression of HOX 
genes leads to developmental defects [92–94]. Active 
HOX genes cluster into transcriptionally active domains 
as shown using chromatin conformation capture analyses 
in mouse embryonic tissues [95]. Similarly, HOXA gene 
regulation is also important in adult tissues since their 
aberrant expression is associated with various cancers 
[34]. Furthermore, CTCF is an important regulator of the 
3D organization and silencing of the HOXA gene cluster 
[40]. Notably, CTCF is associated closer to the 5’ region 
of the HOX gene cluster, in a manner that does not 
overlap with Nup93 binding sites, suggesting the com-
plementary and potentially independent roles of Nup93 
and CTCF in the maintenance of HOXA gene repression. 
However, it is unclear if CTCF silences HOXA gene clus-
ter in differentiated cells by recruiting regulatory proteins 
such as PRC2. We showed that Nup93 depletion in DLD1 
cells did not alter the levels of CTCF or PRC2 complex 
proteins—EZH2, Suz12 and EED (Fig.  7c). We surmise 
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that CTCF or PRC2 proteins may have altered chromatin 
occupancy in the absence of Nup93 sub-complex, which 
remains to be elucidated by ChIP-sequencing of CTCF 
or PRC2 complex proteins in the absence of Nup93 [38]. 
This is further consistent with the significant upregula-
tion of the GLCCI1 gene in cells depleted of both Nup93 
and CTCF as compared CTCF-depleted cells (Fig. 7f ).
We speculate a novel role for Nup93 and its interactors 
in regulating chromatin compaction of the HOXA gene 
cluster in a mechanism that curtails the aberrant expres-
sion of HOXA genes. Our studies open up challenging 
new frontiers for identifying the structural and molecular 
mechanisms of nucleoporin-mediated chromatin organi-
zation and function in paradigms of development, differ-
entiation and disease.
Conclusions
Our studies unravel a novel role for nucleoporins Nup93 
and its interactors Nup188 and Nup205 in mediating 
the repression and tethering of the HOXA gene cluster 
to the nuclear periphery in diploid DLD1 cells. Deple-
tion of Nup93, Nup188 or Nup205 significantly enhances 
HOXA gene expression. The elevated levels of HOXA 
gene expression upon the depletion of Nup93 or its 
interactors—Nup188 and Nup205, is associated with an 
increase in the occupancy of active histone marks, and 
decreased levels of inactive histone marks with a con-
comitant increase in transcriptional elongation marks 
within the HOXA gene.
Methods
Cell culture
Colorectal adenocarcinoma cell line—DLD1, was a gift 
from the laboratory of Thomas Ried. DLD1 cells were 
cultured in RPMI media (Invitrogen, 11875), supple-
mented with 10% fetal bovine serum (FBS, Invitrogen, 
6140-079, Carlsbad, USA), 100 U/ml penicillin/100 µg/ml 
of streptomycin at 37 °C with 5% CO2. The authenticity of 
DLD1 cells was validated independently by karyotyping 
(data not shown).
Transient siRNA‑mediated knockdown and overexpression
Transient knockdowns were performed using siRNA 
oligonucleotides from Dharmacon, USA. Briefly, DLD1 
cells (~0.2  ×  106) were plated in individual wells of 
a six-well plate, 24  h prior to transfection for cells to 
attain a confluency of ~50–60%. The cells were trans-
fected with siRNA oligonucleotides (50  nM) using 
RNAiMax (Invitrogen). After 48  h of knockdown, cells 
were processed for Western blots or RNA extraction. 
For recovery experiments, cells were allowed to recover 
in culture for 8  days after 48  h of Nup93, Nup188 and 
Nup205 depletion. Nup93 knockdown was performed 
by using a combination of oligo-1 (5′GCGCTAATTTA 
CTACTGCA3′) and oligo-2 (5’AGAGTGAAGTGGCG 
GACAA3′)—25 nM each. Two independent siRNA oligos 
against Nup188, Nup205 and Nup98 were tested for 
their knockdown efficiency. Nup188 oligo-1 (5′GGUAG 
UAGGCAGACCAAUAUU3′), oligo_2 (5′GCCTTTCTG 
CGCTTGATCACCACCC3′); Nup205 oligo-1 (5′GGAA 
UUAAUCCCAGAACUAUU3′), oligo2-(5′AGAUGGUG 
AAGGAGGAAUAUU3′); Nup98 oligo-1 (5′GTGAAG 
GGCTAAATAGGAA3′), oligo-2 (5′TGTCAGACCCT 
AAGAAGAA3′). CTCF knockdown was performed using 
a single oligo (5′CAAGAAGCGGAGAGGACGA3′) at a 
final concentration of 50 nM. ON-TARGETplus non-tar-
geting siRNA (siNeg, Dharmacon) was used as a negative 
control.
For overexpression experiments, cells were first trans-
fected with siRNA against Nup188 and Nup205 using 
Lipofectamine RNAi-Max reagent (Invitrogen). After 
24 h, cells were washed with DPBS and transfected with 
full-length Nup93 (Nup93-pEGFP-N1) using Mirus2020 
reagent (cat. MIR5400). After 48 h of Nup93-GPF trans-
fection, cells were either fixed with 4% paraformaldehyde 
or harvested for RNA extraction using Trizol. Nup93-
GFP construct was a kind gift from Radha Chauhan.
Protein extraction and immunoblotting
Cells were lysed in RIPA buffer (50  mM Tris–Cl pH 
7.4, 150  mM NaCl, 0.1% SDS, 0.1% sodium azide, 0.5% 
sodium deoxycholate, 1 mM EDTA, 1% NP-40, 1× pro-
tease inhibitor cocktail) and centrifuged at 13,000g for 
10 min at 4 °C. The supernatant was separated and used 
for protein estimation using BCA kit (cat no. 23225). 
Total protein (20  µg, estimated to be within the linear 
range of detection) was used for each sample prepara-
tion. Samples were lysed in 1× Laemmli buffer (Tris–
HCl pH 6.8, 2% SDS, 20% glycerol, 0.2% bromophenol 
blue, 0.025% β-mercaptoethanol) and denatured at 95 °C 
for 5 min. Protein samples were resolved by SDS-PAGE 
and were transferred to activated polyvinylidene fluoride 
membrane (PVDF, Millipore, cat no. IPVH00010), fol-
lowed by blocking with 5% nonfat-dried skim milk/1× 
TBST (Tris-buffer saline, 0.1% Tween 20) for 1 h at RT. 
Primary antibodies were diluted in 0.5% milk/1× TBST 
buffer. All antibody dilutions are within the linear range 
of detection. Rabbit anti-Nup93 (1:500, sc-292099, Lot-
E0211, Santa Cruz Biotechnology, CA), rabbit anti-
Nup188 (1:1000, Abcam, ab86601, Lot-GR43443-4), 
mouse anti-Nup98 (1:500, sc-74553, Lot-H0108, Santa 
Cruz Biotechnology, Santa Cruz, CA), rabbit anti-
Nup205 antibody (1:500, HPA024574, Lot-R11937, 
Atlas Antibodies), rabbit anti-EED (1:500, ab4469, 
Lot-GR51357-1), rabbit anti-EZH2 (1:500, ab3748, 
Lot-GR252135-1), rabbit anti-Suz12 (1:500, ab12073, 
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Lot-GR79631-1) and rabbit anti-CTCF antibody (1:500, 
07-729, Lot-2375606, Millipore). Secondary antibodies: 
donkey anti-rabbit immunoglobulin G horseradish per-
oxidase (1:10,000, GE NA9340V) and sheep anti-mouse 
immunoglobulin G-HRP (1: 10,000, NA9310V) were 
diluted in 0.5% milk (1× TBST). The blots were devel-
oped using enhanced chemiluminescence detection rea-
gents (ECL Prime, 89168-782) at incremental exposures 
of 10  s acquired under a chemiluminescence system 
LAS4000 (GE). Densitometry analysis of Western blots 
was done using ImageJ software from three independent 
biological replicates. GAPDH was used as internal con-
trol for normalization.
Reverse transcription‑PCR and real‑time quantitative PCR
Cells were washed with 1X PBS, and total RNA was 
extracted using Trizol method [96]; cDNA was synthe-
sized from total RNA with the ImProm-II reverse tran-
scription system using Oligo(dT) primers (Promega, 
A3800); cDNA was used as a template and RT-PCR was 
carried out using intron–exon junction primers (Addi-
tional file 5: Table S1). β-actin and glyceraldehyde-3-phos-
phate dehydrogenase (GAPDH) were used as internal 
controls. The template cDNA was serially diluted to opti-
mize the extent of amplification in the linear range. Real-
time quantitative PCR was performed using Bio-Rad 
RT-PCR instrument (CFX96 Touch) in 10  µl of reaction 
mixtures containing KAPA SYBR Green RT-PCR mix and 
2 µM each of the forward and reverse primer, respectively 
(Additional file  5: Table S2). Fold change was calculated 
by double normalization of Ct values to the internal con-
trol and untreated samples by 2−Ct method [97].
Immunoprecipitation (IP) and Co‑IP
Cells were lysed using IP lysis buffer (50  mM HEPES—
pH 8.0, 140  mM NaCl, 1% NP-40, 0.1% sodium deoxy-
cholate, 0.1% SDS and 1 mM EDTA) in the presence of 
1X complete protease inhibitor cocktail (PIC). Lysates 
were pre-cleared using protein A dynabeads (Invitro-
gen, 10002D), 1 h at 4 °C. Pre-cleared extracts were incu-
bated overnight at 4  °C with anti-Nup93, anti-Nup205 
and anti-Nup188 antibodies independently (2 μg/500 μg 
of total protein). IP complexes were captured using pro-
tein A dynabeads (pre-blocked with 0.5% BSA/1X PBS) 
and washed with lysis buffer and high salt wash buffer-1 
(500 mM NaCl in lysis buffer), and wash buffer-2 (20 mM 
Tris–HCL (pH 8.0), 1 mM EDTA, 0.5% NP-40 and 50× 
PIC). Elution was performed using Laemmli loading 
buffer and analyzed by Western blotting. For Co-IP, cells 
were lysed in Co-IP buffer (50  mM Tris–HCl, pH 8.0, 
150 mM NaCl and 0.5% NP-40) supplemented with pro-
tease inhibitor cocktail. Co-IP washes were performed in 
the same Co-IP lysis buffer.
Chromatin immunoprecipitation
DLD1 cells (~1.0 × 107) were cross-linked using 1% for-
maldehyde for 10 min at RT. Cross-linking was quenched 
using 150 mM glycine, and cells were lysed in 1 ml swell-
ing buffer (25 mM HEPES pH 8.0, 1.5 mM MgCl2, 10 mM 
KCl, 0.1% NP-40, 1X PIC), and nuclei were recovered 
by centrifugation at 2000  rpm. Fixed nuclei were re-
suspended in 1 ml sonication buffer (50 mM HEPES pH 
8.0, 140 mM NaCl, 1 mM EDTA, 1% Triton-X-100, 0.1% 
sodium deoxycholate and 0.1% SDS) supplemented with 
protease inhibitor cocktail and sonicated using Bioruptor 
Twin sonicator (Diagenode) to generate fragment sizes 
of ~100–500  bp. Sonicated chromatin was separated by 
centrifugation at 13,000g at 4 °C for 10 min. Supernatant 
was pre-cleared using protein A dynabeads (Invitrogen), 
1  h at 4  °C. The amount of DNA was estimated using 
NanoDrop 2000. Nup93 antibody validated according 
to ENCODE guidelines (~2  µg) was added to ~100  µg 
of chromatin sample and diluted to ~1 ml in sonication 
buffer and incubated overnight at 4 °C [98]. IP complexes 
were captured using protein A dynabeads (pre-blocked 
with 0.5% BSA/1X PBS) and washed three times (at 4 °C, 
11 rpm on end-to-end rotor) each with sonication buffer, 
wash buffer-1 (50  mM HEPES pH 8.0, 500  mM NaCl, 
1 mM EDTA, 1% Triton X-100, 0.1% sodium deoxycho-
late and 0.1% SDS), wash buffer-2 (20  mM Tris–HCL 
pH 8.0, 1  mM EDTA, 0.5% NP-40, 250  mM LiCl, 0.5% 
sodium deoxycholate and 1× PIC) and TE buffer. Immu-
noprecipitated chromatin was eluted twice in 200  µl of 
elution buffer (50  mM Tris-HCL pH 8.0, 1  mM EDTA, 
1% SDS, 50 mM NaHCO3) at 65 °C for 10 min. Input and 
IP fractions were treated with 20 µg RNase A for 1 h at 
42  °C followed by 40  µg Proteinase K for 1  h at 65  °C. 
Reverse cross-linking was performed overnight at 65 °C. 
DNA was extracted with phenol/chloroform/isoamyl 
alcohol (25:24:1), ethanol precipitated using 3 M sodium 
acetate (pH 5.2) and 2 µg of glycogen. DNA samples were 
washed with 70% ethanol and re-suspended in 10  µl of 
nuclease free water. ChIP-PCR was performed using 
primers listed in Additional file  5: Table S1. DNA was 
quantified by real-time qPCR, and fold enrichment over 
input was calculated by % input method from 2−Ct [97, 
99]. All ChIP-qPCR experiments were performed in two 
independent biological replicates as recommended in the 
ENCODE guidelines [100].
Three‑dimensional fluorescence in situ hybridization 
(3D‑FISH)
3D-FISH assays were performed as described previously 
[101]. DLD1 cells (~0.2 × 106) were seeded on coverslips 
in a six-well plate. After 48  h of Nup93 knockdown, the 
cells were washed with ice-cold 1× PBS and treated with 
cytoskeletal (CSK) digestion buffer (0.1  M NaCl, 0.3  M 
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sucrose, 3 mM MgCl2, 10 mM PIPES (pH 7.4), 0.5% Tri-
ton X-100) for 5  min followed by fixation with 4% PFA 
in 1X PBS (pH 7.4) for 10 min at RT. The cells were per-
meabilized in 0.5% Triton X-100 (prepared in 1× PBS) 
for 10 min and incubated in 20% glycerol (prepared in 1× 
PBS) for 60 min followed by four freeze–thaw cycles in liq-
uid nitrogen. The cells were washed three times in 1× PBS 
and treated with 0.1 N HCl for 10 min followed by three 
washes in 1× PBS for 5 min each. The cells were incubated 
in 50% formamide (FA)/2  ×  saline sodium citrate (SSC) 
(pH 7.4) overnight at 4 °C or until used for hybridization. 
Cells were hybridized with 3  µl of human whole chro-
mosome 7 paint (Applied Spectral Imaging (ASI), Israel, 
or MetaSystems, USA) and nick-translated BAC DNA 
probe (RP11-1132K14) for HOXA gene locus (3 µl). Post-
hybridization, coverslips were washed in 50% FA/2× SSC 
(pH 7.4), thrice for 5 min each at 45 °C, followed by three 
washes for 5  min each in 0.1× SSC at 60  °C. Coverslips 
were then counterstained with DAPI for 2 min, washed in 
2× SSC and mounted in Slowfade Gold antifade (Invitro-
gen S36937). Image acquisition was performed on a Leica 
SP8 confocal microscope with a 63X Plan-Apo1.4 NA oil 
immersion objective using scan zoom of 2.5. Acquisition 
of Z-stacked images (voxel size of 0.105 μm  ×   0.105 μm  
×  0.30 μm) was at 512  ×  512 pixels per frame using 8-bit 
pixel depth for each channel. The line averaging was set to 
4, and images were collected sequentially in a three-chan-
nel mode. Distances of gene loci from the nuclear periph-
ery were measured (in μm) in 3D using the boundary of 
the DAPI signal as a marker of the nuclear periphery [50]. 
Briefly, surface rendering was performed for the nucleus 
(blue channel), HOXA gene locus (red channel), CT7 
(green channel), using Huygens Professional software.
Nuclear import assay
Nuclear import assay was performed as described pre-
viously [53]. DLD1 cells (~0.2  ×  106) were seeded on 
coverslips in a six-well plate. After 24 h of siRNA trans-
fection, cells were transfected with the vector encod-
ing GR2-GFP2-M9core fusion protein. After 48  h of 
transfection, cells were treated with 5  μM dexametha-
sone (Sigma) for 30  min at 37  °C and fixed with 4% 
paraformaldehyde. Cells were permeabilized with 0.5% 
Triton X-100 and immunostained with Phalloidin-Alexa 
594 (Invitrogen, cat. A12381) to mark the cell bound-
ary. Finally, cells were stained with DAPI and mounted 
in antifade solution. Images were acquired using Leica 
SP8 confocal microscopy using a 63× objective/N.A. 1.4 
using 405, 488 and 594  nm and lasers, zoom set to 2.0. 
The mean fluorescence intensity of the GFP signal was 
determined for each cell (demarcated by phalloidin) and 
nucleus (demarcated by DAPI), and expressed as a ratio 
of the nuclear to cytoplasmic fluorescence intensity using 
ImageJ. Nuclear/cytoplasmic (N/C) fluorescence inten-
sity ratios were calculated and plotted using GraphPad 
Prism software. Statistical analysis was performed using 
Mann–Whitney test. The GR2-GFP2-M9 construct was a 
kind gift from Ralph Kehlenbach.
Poly(A) fluorescence in situ hybridization (FISH)
DLD1 cells (~0.2 ×  106) were seeded on coverslips in a 
six-well plate. After 48 h of Nup93 knockdown, the cells 
were fixed with 4% PFA in 1× PBS (pH 7.4) for 15 min 
at RT. Cells were re-fixed and permeabilized with chilled 
methanol for 5  min, followed by incubation in 2× SSC 
at RT for 10  min. Cells were hybridized with 100  µl of 
hybridization mix (40% formamide, 10% dextran sulfate, 
0.1 mg salmon sperm DNA and 5 ng/ml of FAM oligo dT 
prepared in 2× SSC solution) at 37 °C for 3 h. Coverslips 
were washed twice with 2× SSC, followed by washes with 
0.1× SSC. Cells were stained with DAPI and mounted in 
antifade solution. Images were acquired using confocal 
microscopy using a 63× objective/N.A. 1.4 using 488 and 
405  nm lasers, zoom set to 1.0. The mean fluorescence 
intensity of the FISH signal was determined for each cell 
and nucleus (demarcated by DAPI), and expressed as a 
ratio of the nuclear to cytoplasmic fluorescence intensity 
using the Cell Profiler software [102]. Nuclear/cytoplas-
mic (N/C) fluorescence intensity ratios were calculated 
and plotted using GraphPad Prism software. Statistical 
analysis was performed using Mann–Whitney test.
Data accession from WashU Epigenome Browser
WashU Epigenome Browser was used to visualize the 
openly available CTCF (GSM749729) ChIP-seq data 
from HeLa cells.
Antibodies used: All antibodies and their dilutions used 
in this study are provided in Additional file 5: Table S3.
Additional files
Additional file 1: Figure S1. a Co-Immunoprecipitation of Nup93 upon 
depletion of Nup205, shows reduced interaction between Nup93 and 
Nup188. b Nup93 ChIP PCR experiment was performed in Nup188 and 
Nup205 depleted cells, a representative gel image from 2 independent 
biological replicates. c ChIP qPCR for control PanH3 in siNeg, Nup188 and 
Nup205Kd cells, Y-axis represents immunoprecipitated DNA relative to 1% 
input (N = 2, independent biological replicates). d qRT-PCR analyses was 
performed upon Nup93, Nup188 and Nup205 depletion to check their rel-
ative transcript levels. Y-axis indicates fold change in levels of mRNA nor-
malized to untreated cells. Error bars: S.E.M, data from a single experiment 
that includes 3 technical replicates. e qRT-PCR analyses upon Nup93 over 
expression in a background of Nup188 or Nup205 depletion as indicated. 
Y-axis indicates fold change in levels of mRNA normalized to untreated 
cells. Error bars: S.E.M, data from two biological replicates that includes 
6 technical replicates. f Western blot quantification of Fig. 2e from 3 
independent biological replicates. Y-axis: relative band intensity quantified 
using Image-J. g Ponceaue staining for western blot represented in Fig. 2e.
Additional file 2: Figure S2. a Two independent siRNA oligos were 
used to knockdown Nup93, Nup188, Nup205 and Nup98.A representative 
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